B cell antigen presentation in models of B cell a*

B 细胞 a* 模型中的 B 细胞抗原呈递

基本信息

  • 批准号:
    7387451
  • 负责人:
  • 金额:
    $ 6.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-01 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is a chronic, multisystem human autoimmue disease characterized by the differentiation of short- and long-lived plasma cells (PCs) that secrete autoantibodies. Although the exact cause of SLE is unclear, environmental factors such as polyclonal B cell activation by bacterial and/or viral infection seem to play a significant role in the emergence of disease. In this case, it is anticipated that activated autoreactive B cells may participate in germinal center reaction and remain as memory cells long after infection, which may give rise to long-lived PCs secreting autoantibodies. We propose a hypothesis that memory B cells can differentiate into PCs only when receiving CD40/CD40L signals by antigen presentation to T cells. However, immunomodulatory factors such as CpG DNA may bypass this pathway, which potentially results in generation of autoreactive long-lived PC. We recently generated IA-B mice that lack MHC-II on about 95% of all B cells due to B-cell-restricted deletion of a loxP-flanked iab-neo allele by the cd19cre (Cre recombinase) transgene. Upon immunization with a T cell dependent antigen, a small number of antigen-specific MHC-II+ B cells in IA-B mice dramatically expand to differentiate into GC B cells and make normal levels of B220+ CD38+ memory B cells. However, these memory B cells lose MHC-II expression later because of ongoing deletion of MHC-II by the cd19cre transgene. In association with loss of MHC-II on memory B cells, IA-B mice showed impaired affinity maturation in long-lived PCs. With use of IAB mice, the specific aims to test our hypothesis are: 1) determination of the role of CD40/CD40L signal on memory B cell differentiation to long-lived PC by using IA-B mice carrying B cell specific CD40L transgene, and 2) determination of the effect of immunomodulatory factors that can bypass the requirement of MHC-II dependent antigen-presentation to T cells in long-lived PC differentiation. The outcome will provide a great help for understanding the development of autoreactive long-lived PCs and create new avenues for exploring therapy for SLE patients.
描述(由申请人提供):系统性红斑狼疮(SLE)是一种慢性、多系统的人类自身免疫性疾病,其特征是分泌自身抗体的短寿命和长寿命浆细胞(PC)的分化。虽然SLE的确切病因尚不清楚,但环境因素如细菌和/或病毒感染引起的多克隆B细胞活化似乎在疾病的发生中起重要作用。在这种情况下,预期活化的自身反应性B细胞可能参与生发中心反应,并在感染后长时间保持为记忆细胞,这可能产生分泌自身抗体的长寿命PC。我们提出了一个假设,即记忆B细胞只有在接受CD 40/CD 40 L信号时才能分化为PC。然而,免疫调节因子如CpG DNA可能绕过这一途径,这可能导致自身反应性长寿命PC的产生。我们最近产生了IA-B小鼠,由于cd 19 cre(Cre重组酶)转基因对loxP侧翼的iab-neo等位基因的B细胞限制性缺失,约95%的所有B细胞上缺乏MHC-II。在用T细胞依赖性抗原免疫后,IA-B小鼠中的少量抗原特异性MHC-II+ B细胞显著扩增以分化成GC B细胞并产生正常水平的B220+ CD 38+记忆B细胞。然而,这些记忆B细胞由于通过cd 19 cre转基因持续缺失MHC-II而在以后失去MHC-II表达。与记忆B细胞上MHC-II的缺失相关,IA-B小鼠在长寿命PC中表现出亲和力成熟受损。使用IA B小鼠,检验我们假设的具体目的是:1)通过使用携带B细胞特异性CD 40 L转基因的IA-B小鼠,确定CD 40/CD 40 L信号在记忆B细胞分化为长寿PC中的作用,和2)确定可以绕过在长寿PC分化中对T细胞的MHC-II依赖性抗原呈递的需要的免疫调节因子的作用。这一结果将为了解自身反应性长寿命PC的发展提供很大的帮助,并为探索SLE患者的治疗开辟新的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHIKO SHIMODA其他文献

MICHIKO SHIMODA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHIKO SHIMODA', 18)}}的其他基金

Long-lived plasma cell differentiation
长寿命浆细胞分化
  • 批准号:
    7497525
  • 财政年份:
    2007
  • 资助金额:
    $ 6.99万
  • 项目类别:
Long-lived plasma cell differentiation
长寿命浆细胞分化
  • 批准号:
    7255975
  • 财政年份:
    2007
  • 资助金额:
    $ 6.99万
  • 项目类别:
Beta cell antigen presentation in models of Beta cell a*
Beta 细胞 a* 模型中的 Beta 细胞抗原呈递
  • 批准号:
    7038622
  • 财政年份:
    2006
  • 资助金额:
    $ 6.99万
  • 项目类别:
B cell antigen presentation in models of B cell a*
B 细胞 a* 模型中的 B 细胞抗原呈递
  • 批准号:
    7192581
  • 财政年份:
    2006
  • 资助金额:
    $ 6.99万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 6.99万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了